Data for: Metastatic Pattern Discriminates Survival Benefit of Primary Surgery for De Novo Stage IV Breast Cancer: A Real-World Observational Study
收藏官方服务：
资源简介：
SEER database
应用场景：
创建时间：
2019-07-20
相关数据集
Data_Sheet_1_Economic evaluation of margetuximab vs. trastuzumab for pretreated ERBB2-positive advanced breast cancer in the US and China.DOCX
ObjectiveTo assess the economic evaluation of margetuximab plus chemotherapy over trastuzumab plus chemotherapy for women with pretreated ERBB2-positive advanced breast cancer in the United States (US
NIAID Data Ecosystem290
Global treatment costs of breast cancer by stage: A systematic review
Background Published evidence on treatment costs of breast cancer varies widely in methodology and a global systematic review is lacking. Objectives This study aimed to conduct a systematic review to
NIAID Data Ecosystem50
Table_4_Cost-Effectiveness Analysis of Imaging Modalities for Breast Cancer Surveillance Among BRCA1/2 Mutation Carriers: A Systematic Review.doc
BackgroundBRCA1/2 mutation carriers are suggested with regular breast cancer surveillance screening strategies using mammography with supplementary MRI as an adjunct tool in Western countries. From a
NIAID Data Ecosystem30
Table_2_Metastatic Pattern Discriminates Survival Benefit of Type of Surgery in Patients With De Novo Stage IV Breast Cancer Based on SEER Database.xlsx
Background: The role of surgery and surgery type in de novo stage IV breast cancer (BC) is unclear. Methods: We carried out a retrospective cohort study that included the data of 4,108 individuals wit
NIAID Data Ecosystem50
Supplementary Material for: Lobular Breast Cancer and Abdominal Metastases: A Retrospective Review and Impact on Survival
Background: The predominant breast cancer subtypes, invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC), have similar recurrence and survival rates but differing patterns of metastati
NIAID Data Ecosystem40
